Literature DB >> 9092748

Acquired angioedema.

W R Heymann1.   

Abstract

Acquired angioedema (AAE) is a rare disorder that has been categorized into two forms, AAE-I and AAE-II. AAE-I is associated with other diseases, most commonly B-cell lymphoproliferative disorders. AAE-II is defined by the presence of an autoantibody directed against the C1-inhibitor molecule. Differentiating AAE-I from AAE-II is vital because different therapeutic interventions are required for each type. This review summarizes the clinical aspects, pathophysiology, and management of AAE compared with the types of hereditary angioedema.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092748     DOI: 10.1016/s0190-9622(97)70250-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  8 Inhibitors.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 3.  Angioedema. Pathogenesis, differential diagnosis, and treatment.

Authors:  Evangelo Frigas; Ugochukwu C Nzeako
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

4.  Ticagrelor-Induced Angioedema: A Rare and Unexpected Phenomenon.

Authors:  Rajeev Seecheran; Valmiki Seecheran; Sangeeta Persad; Sasha Lalla; Naveen Anand Seecheran
Journal:  Case Rep Cardiol       Date:  2017-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.